Abstract: A method of preparing a carbon fiber including: preparing a precursor fiber for preparing a carbon fiber; and stabilizing the precursor fiber. The stabilization of the precursor fiber includes a first stabilization phase, a second stabilization phase, a third stabilization phase, and a fourth stabilization phase, which are set at four different temperatures between a temperature at which heat starts to be generated from the stabilization reaction of the precursor fiber and a temperature at which the generation of heat is maximized. Ozone gas is input while at least one phase of the third stabilization phase and the fourth stabilization phase is carried out.

Abstract: The display device includes a display panel and a pixel. A compensator configured to calculate a degradation rate of the pixel based on an input gray level of first image data, and compensates the first image data based on the degradation rate to generate second image data. A data driver configured to generate a data signal based on the second image data and configured to supply the data signal to the pixel. The pixel includes a first element group and a second element group connected in series to each other, the first element group includes at least one first light emitting element, and the second element group includes at least one second light emitting element. The compensator is to calculate the degradation rate by applying first information on the number of the first light emitting elements and second information on the number of the second light emitting elements.

Abstract: The present invention relates to a composition for preventing, improving, or treating diseases related to advanced glycation end products, comprising an indole derivative or a pharmaceutically acceptable salt thereof. Specifically, the composition of the present invention possesses the effect of trapping methylglyoxal (MGO), which is a main precursor of advanced glycation end products, and thus can be effectively used for preventing, improving, or treating diseases related to advanced glycation end products.

Abstract: The present invention relates to a novel indole derivative and a use thereof. The novel indole derivative according to the present invention traps methylglyoxal (MGO), which is a main precursor of advanced glycation end products, and thus can be effectively used for preventing, improving, or treating diseases related to advanced glycation end products.

Abstract: The present inventive concept relates to a method for improving a lifespan of a liquid crystal display (LCD) of a masked stereolithography (MSLA) 3D printer, the method including the steps of: slicing a three-dimensional (3D) image into two-dimensional (2D) images; outputting the 2D images to the LCD; calculating irradiation area coordinates of UV LEDs in accordance with the 2D images; and irradiating UV light of the UV LEDs on an area matching with the 2D images in accordance with the calculated irradiation area coordinates of the UV LEDs.

Abstract: The present inventive concept relates to a method for improving a lifespan of a liquid crystal display (LCD) of a masked stereolithography (MSLA) 3D printer, the method including the steps of: slicing a three-dimensional (3D) image into two-dimensional (2D) images; outputting the 2D images to the LCD; calculating irradiation area coordinates of UV LEDs in accordance with the 2D images; and irradiating UV light of the UV LEDs on an area matching with the 2D images in accordance with the calculated irradiation area coordinates of the UV LEDs.

Abstract: Disclosed is a seawater desalination method. The method includes reading parameters representing properties of one or more membranes constituting a membrane combination to be applied to each membrane module; calculating water flux and salt flux of the membrane modules based on the read parameters; calculating a volumetric flow rate imbalance and a total permeate flow rate of the membrane modules based on the calculated water flux and salt flux; and determining a membrane combination having a minimum volumetric flow rate imbalance and a maximum total permeate flow rate based on the calculated volumetric flow rate imbalance and total permeate flow rate. Thus, it is possible to achieve arrangement optimization of reverse osmosis membrane modules.

Abstract: Disclosed is a seawater desalination method. The method includes reading parameters representing properties of one or more membranes constituting a membrane combination to be applied to each membrane module; calculating water flux and salt flux of the membrane modules based on the read parameters; calculating a volumetric flow rate imbalance and a total permeate flow rate of the membrane modules based on the calculated water flux and salt flux; and determining a membrane combination having a minimum volumetric flow rate imbalance and a maximum total permeate flow rate based on the calculated volumetric flow rate imbalance and total permeate flow rate. Thus, it is possible to achieve arrangement optimization of reverse osmosis membrane modules.

Abstract: Provided are a water treatment system and method for continuous forward osmosis process using OAC with phase transition, where the OAC with easy phase changes is applied and thereby separation and recovery processes of the draw solution may be performed through continuous processes of a forward osmosis type, and a method thereof. In the water treatment system and method for continuous forward osmosis process using OAC with phase transition according to the exemplary embodiments of the present invention, the OAC with easy phase changes is applied so that separation and recovery processes of the draw solution can be performed through continuous processes of a forward osmosis type, thereby making it possible to produce drinking water. The water treatment process where the OAC with easy phase changes is applied can be used in all water treatment processes of waste water or groundwater, as well as seawater desalination.

Abstract: The present invention relates to a method for measuring degree of biological contamination in a sea water desalination facility, and is characterized by comprising the following steps of: a) collecting any one selected from a group consisting of raw sea water flowing into the sea water desalination facility, pre-treated water prepared by pre-treating the raw sea water, product water (permeate) produced after the pre-treated water goes through a desalination process and brine; and b) measuring wavelength and strength of a natural phosphor, which is contained in the raw sea water, pre-treated water, product water (permeate) or brine, using a fluorescence spectrophotometer.

Abstract: The present invention relates to a method for measuring degree of biological contamination in a sea water desalination facility, and is characterized by comprising the following steps of: a) collecting any one selected from a group consisting of raw sea water flowing into the sea water desalination facility, pre-treated water prepared by pre-treating the raw sea water, product water (permeate) produced after the pre-treated water goes through a desalination process and brine; and b) measuring wavelength and strength of a natural phosphor, which is contained in the raw sea water, pre-treated water, product water (permeate) or brine, using a fluorescence spectrophotometer.